“…Because clinical improvement is not objective, it seems essential to measure immunological parameters during vaccine therapy. Remy et al (1976) reported a follow-up study of antibody titres in patients treated with HSV type 2 vaccine. Over a period of nine months the titres remained almost constant; this suggests an important role for cell-mediated immunity in herpes recurrences.…”